Deferred Tax Assets, Valuation Allowance of BIOLIFE SOLUTIONS INC from 31 Dec 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BIOLIFE SOLUTIONS INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2025.
  • BIOLIFE SOLUTIONS INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $50,759,000, a 13% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

BIOLIFE SOLUTIONS INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $50,759,000 -$7,574,000 -13% 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q4 2024 $58,333,000 +$8,816,000 +18% 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q1 2024 $54,700,000 +$14,600,000 +36% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $49,517,000 +$16,115,000 +48% 31 Dec 2023 10-K 26 Feb 2026 2025 FY
Q3 2023 $48,200,000 +$27,700,000 +135% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $44,100,000 +$22,500,000 +104% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $40,100,000 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $33,402,000 +$30,409,000 +1016% 31 Dec 2022 10-K 03 Mar 2025 2024 FY
Q3 2022 $20,500,000 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $21,600,000 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q4 2021 $2,993,000 -$5,505,000 -65% 31 Dec 2021 10-K 03 Mar 2025 2024 FY
Q4 2020 $8,498,000 -$208,000 -2.4% 31 Dec 2020 10-K 29 Feb 2024 2023 FY
Q4 2019 $8,706,000 +$361,000 +4.3% 31 Dec 2019 10-K 31 Mar 2023 2022 FY
Q4 2018 $8,345,000 -$412,000 -4.7% 31 Dec 2018 10-K 31 Mar 2022 2021 FY
Q4 2017 $8,757,000 -$3,419,595 -28% 31 Dec 2017 10-K 15 Mar 2019 2018 FY
Q4 2016 $12,176,595 +$38,090 +0.31% 31 Dec 2016 10-K 09 Mar 2018 2017 FY
Q4 2015 $12,138,505 +$22,846,719 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q4 2014 $10,708,214 -$1,122,900 -12% 31 Dec 2014 10-K 25 Feb 2016 2015 FY
Q4 2013 $9,585,314 -$342,174 -3.7% 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q4 2012 $9,243,140 -$30,403 -0.33% 31 Dec 2012 10-K 12 Feb 2014 2013 FY
Q4 2011 $9,212,737 31 Dec 2011 10-K 29 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.